. Current status of fluid biomarkers for early Alzheimer's disease and FDA regulation implications. J Neurol Sci. 2024 Dec 15;467:123325. Epub 2024 Nov 22 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.